HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Claude Gagné Selected Research

Isotopes

9/2006Effects of fenofibrate on apolipoprotein kinetics in patients with coexisting dysbetalipoproteinemia and heterozygous familial hypercholesterolemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Claude Gagné Research Topics

Disease

14Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2018 - 02/2002
7Cardiovascular Diseases (Cardiovascular Disease)
01/2018 - 11/2005
7Atherosclerosis
07/2010 - 05/2002
5Coronary Artery Disease (Coronary Atherosclerosis)
01/2009 - 05/2004
4Hypercholesterolemia
06/2015 - 11/2002
4Dyslipidemias (Dyslipidemia)
01/2009 - 09/2006
4Hypertriglyceridemia
03/2008 - 06/2006
3Type 2 Diabetes Mellitus (MODY)
03/2008 - 06/2007
3Hyperlipoproteinemia Type III (Broad Beta Disease)
08/2007 - 09/2004
1Xanthomatosis (Xanthoma)
01/2018
1Myalgia
11/2015
1Hypobetalipoproteinemias (Hypobetalipoproteinemia)
09/2011
1Carotid Artery Diseases
07/2010
1Inflammation (Inflammations)
03/2008
1Hyperlipoproteinemias
08/2007
1Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia)
08/2007
1Obesity
02/2007
1Inborn Genetic Diseases (Disease, Hereditary)
09/2006
1Hypertension (High Blood Pressure)
11/2005
1Vitiligo
05/2004
1Abetalipoproteinemia (Bassen Kornzweig Syndrome)
02/2004
1Coronary Disease (Coronary Heart Disease)
03/2003
1Homozygous Familial Hypercholesterolemia
05/2002

Drug/Important Bio-Agent (IBA)

13oxidized low density lipoproteinIBA
01/2018 - 05/2002
9Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2013 - 05/2002
7Triglycerides (Triacylglycerol)IBA
03/2008 - 02/2004
6Lipoproteins (Lipoprotein)IBA
01/2018 - 02/2002
6LipidsIBA
06/2015 - 02/2005
6ApolipoproteinsIBA
09/2011 - 02/2004
6Simvastatin (Zocor)FDA LinkGeneric
10/2008 - 02/2002
5LDL Receptors (LDL Receptor)IBA
01/2006 - 02/2002
4Apolipoproteins B (ApoB)IBA
01/2018 - 02/2004
4LDL CholesterolIBA
01/2018 - 10/2002
4Ezetimibe (Zetia)FDA Link
06/2015 - 05/2002
4Atorvastatin (Lipitor)FDA Link
03/2008 - 05/2002
4CholesterolIBA
08/2007 - 05/2002
3Rosuvastatin Calcium (Crestor)FDA Link
11/2015 - 03/2010
3Fenofibrate (CiL)FDA LinkGeneric
03/2008 - 09/2006
3Apolipoprotein B-100 (Apo B 100)IBA
02/2008 - 05/2004
2Fibric Acids (Fibrates)IBA
03/2008 - 02/2008
2Oxidoreductases (Dehydrogenase)IBA
03/2008 - 02/2008
2HDL CholesterolIBA
03/2008 - 02/2007
2Apolipoprotein B-48IBA
02/2008 - 06/2007
2VLDL LipoproteinsIBA
08/2007 - 02/2004
2Apolipoprotein A-I (Apolipoprotein A1)IBA
02/2007 - 01/2007
1DNA (Deoxyribonucleic Acid)IBA
01/2018
1SelectinsIBA
03/2008
1Coenzyme A (CoA)IBA
03/2008
1Secretory Phospholipases A2IBA
03/2008
1Cell Adhesion MoleculesIBA
03/2008
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
02/2008
1IsotopesIBA
09/2006
1Apolipoproteins AIBA
09/2006
1Lipoprotein Lipase (Diacylglycerol Lipase)IBA
06/2006
1Tuberculin (PPD)IBA
01/2006
1Cholesterol Ester Transfer ProteinsIBA
06/2004
1ChylomicronsIBA
02/2004
1Apolipoproteins E (ApoE)IBA
02/2002

Therapy/Procedure

9Therapeutics
11/2015 - 05/2002
1Blood Component Removal (Apheresis)
05/2002